Skip to content
10-K

Annual Report

DNA X, Inc. SONM

0001493152-26-016659

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 1.49M sh
Shares Diluted FY 2025 · Dec 31, 2025 722.69K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 262.12K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$23.53M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$8.49M
Short Term Debt FY 2025 · Dec 31, 2025 $5.07M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.3M
Cash And Equivalents FY 2025 · Dec 31, 2024 $5.34M
Stockholders Equity FY 2025 · Dec 31, 2025 −$7.96M
Stockholders Equity FY 2025 · Dec 31, 2024 −$5.7M
Stockholders Equity FY 2025 · Dec 31, 2023 $22.37M
Current Liabilities FY 2025 · Dec 31, 2025 $48.03M
Current Liabilities FY 2025 · Dec 31, 2024 $43.74M
Total Liabilities FY 2025 · Dec 31, 2025 $50.63M
Total Liabilities FY 2025 · Dec 31, 2024 $45.44M
Current Assets FY 2025 · Dec 31, 2025 $28.91M
Current Assets FY 2025 · Dec 31, 2024 $32.17M
Total Assets FY 2025 · Dec 31, 2025 $43.9M
Total Assets FY 2025 · Dec 31, 2024 $39.74M
Eps Diluted FY 2025 · Dec 31, 2025 −$28.58
Eps Diluted restated FY 2025 · Dec 31, 2024 −$128.37
Eps Basic FY 2025 · Dec 31, 2025 −$28.58
Eps Basic restated FY 2025 · Dec 31, 2024 −$128.37
Sga Expense FY 2025 · Dec 31, 2025 $5.41M
Sga Expense restated FY 2025 · Dec 31, 2024 $3.1M
Net Income FY 2025 · Dec 31, 2025 −$20.66M
Net Income FY 2025 · Dec 31, 2024 −$33.65M
Operating Income FY 2025 · Dec 31, 2025 −$5.41M
Operating Income restated FY 2025 · Dec 31, 2024 −$3.1M
Capex FY 2025 · Dec 31, 2024 $214K